首页 产品目录 分子砌块 按官能团 酮类 (4aS,6aR,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(5-羟基-2-氧代-2,5-二氢呋喃-3-基)-6,6,8a,12a-四甲基十氢-1H,3H-环氧[2,3-d]吡喃并[4',3':3,3a]异苯并呋喃并[5,4-f]异色烯-3,8,10(6H,9aH)-三酮

(4aS,6aR,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(5-羟基-2-氧代-2,5-二氢呋喃-3-基)-6,6,8a,12a-四甲基十氢-1H,3H-环氧[2,3-d]吡喃并[4',3':3,3a]异苯并呋喃并[5,4-f]异色烯-3,8,10(6H,9aH)-三酮

(4aS,6aR,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(5-hydroxy-2-oxo-2,5-dihydrofuran-3-yl)-6,6,8a,12a-tetramethyldecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

73904-93-5

中文名称

(4aS,6aR,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(5-羟基-2-氧代-2,5-二氢呋喃-3-基)-6,6,8a,12a-四甲基十氢-1H,3H-环氧[2,3-d]吡喃并[4',3':3,3a]异苯并呋喃并[5,4-f]异色烯-3,8,10(6H,9aH)-三酮

英文名称

(4aS,6aR,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(5-hydroxy-2-oxo-2,5-dihydrofuran-3-yl)-6,6,8a,12a-tetramethyldecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione

别名

IsoliMonexic acid;Limonexylic acid;Rutaevinexic acid;(17R,23Xi)-1alpha,4;14,15beta-Diepoxy-17,19,23,23-tetrahydroxy-4,4,8-trimethyl-7-oxo-3,4;16,17-diseco-24-nor-5alpha,13alpha,14beta-chol-20(22)-en-3,16,21-trisaeure-3=>19;Isolimonexin;21=>23-trilacton

标准英文名

(4aS,6aR,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(5-hydroxy-2-oxo-2,5-dihydrofuran-3-yl)-6,6,8a,12a-tetramethyldecahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione

MDL No.

MFCD17214831

分子式

C26H30O10

分子量

502.52

精确分子量

502.18

SMILES

CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]2CC[C@@]4(C)[C@H](C5=CC(O)OC5=O)OC(=O)[C@H]5O[C@]54[C@]2(C)C(=O)C[C@@H]13

标准SMILES

CC1(C)O[C@H]2CC(=O)OC[C@]32[C@H]1CC(=O)[C@]1(C)[C@@H]3CC[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@]213)C1=CC(O)OC1=O

用途

Isolimonexic acid exhibits anticancer activity and anti-aromatase activity (IC50 = 25.60 μM); it shows cytotoxicity against MCF-7 breast cancer cells and time-dependent inhibition of Panc-28 pancreatic cancer cell growth, with 21%, 68%, and 90.58% inhibition at 48, 72, and 144 hours, respectively; it demonstrates no cytotoxicity against MDA-MB-231 breast cancer cells.

InChIKey

DNNFETMOXYZICP-OKRPZFHJSA-N

安全信息

SureRoute逆合成路线

1.  73904-93-5 逆合成路线 1

—
—
ACEAXQ356
73904-93-5
来源: SureRoute

2.  73904-93-5 逆合成路线 2

—
—
—
—
ACEAXQ356
73904-93-5
来源: SureRoute

3.  73904-93-5 逆合成路线 3

—
—
ACEAXQ356
73904-93-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手